menu search

Jasper’s market squawk 16-08-2023

Markets Pressured by Rising Yields A series of data points pushed global yields higher and depressed eq...

August 16, 2023, 9:11 am

Pound to euro exchange rate: uk inflation key risk for gbp today

The Pound Euro exchange rate may trade according to the latest US retail data subsequent to its release. Given the Euro’s negative correlation with ...

August 16, 2023, 4:44 am

Usd/jpy analysis: breakout above 145.06 weekly resistance [video]

Gold fades the late Monday’s corrective bounce off the 200-DMA support by retreating to $1,907, depress...

August 15, 2023, 3:59 am

The 3 most undervalued robotics stocks to buy now: august 2023

If you're an investor constantly on the hunt for promising opportunities, you may see clear bargains emerging in robotics stocks. With valuations ...

August 14, 2023, 4:23 pm

Xenon is well-funded heading into key readouts

Xenon Pharmaceuticals has a strong cash position of $652.2M and an estimated cash runway of approximately 3.11 years. The company's financial health i...

August 13, 2023, 9:20 am

Intra-cellular therapies: caplyta's rise and a promising pipeline

Intra-Cellular Therapies' main drug, Caplyta, has been successful in treating neuropsychiatric conditions and has shown potential in addressing mixed ...

August 12, 2023, 10:29 am

Oaktree speciality lending: portfolio diversifier yielding 11%

Oaktree Specialty Lending is a private credit actor with $179 billion AuM, with a flexible investment strategy. OCSL focuses on first lien loans but a...

August 11, 2023, 11:51 pm

Why shares of sage therapeutics slumped this week

The FDA approved Zurzuvae for postpartum depression but not for major ...

August 11, 2023, 11:23 am

2 reasons to sell upstart stock right now

Upstart's second-quarter results showed solid progress, compared to the first quarter. Loan volumes and revenue are still deeply ...

August 10, 2023, 6:50 am

Aud/usd stays depressed below 0.6550 ahead of australia/us inflation clues

AUD/USD holds lower ground at multi-day bottom after declining in the last two consecutive days. Sour sentiment, fears about China weigh on Aussie des...

August 9, 2023, 11:29 pm

Ready to set sail with a.p. møller - mærsk a/s

Maersk stock is currently depressed due to struggles the global economy faces and stagnant shipping fre...

August 9, 2023, 4:38 am

Gold price forecast: xau/usd edges lower past $1,955 hurdle on firmer us dollar – confluence detector

Gold Price (XAU/USD) remains depressed for the second consecutive day as markets turn slightly downbeat...

August 8, 2023, 4:59 am

Spyi: structurally interesting call strategy with the wrong timing

The Neos S&P 500 High Income ETF aims to provide high monthly income and potential upside appreciation in rising markets. The ETF has seen success wit...

August 8, 2023, 4:53 am

Sage therapeutics shares plummet following fda decision on depression drug

Sage Therapeutic shares fell to an all-time low after the FDA rejected use of its treatment for major depress<...

August 7, 2023, 4:15 pm

Bitcoin is boring again and history says prices will drop

Bitcoin and other cryptocurrencies continued to languish at depressed levels on Monday in what has beco...

August 7, 2023, 1:01 pm

Why sage therapeutics stock is crashing today

The U.S. FDA didn't approve zuranolone in treating major depressive disorder. However, the FDA did appr...

August 7, 2023, 11:44 am

Sage therapeutics stock plunges 48% after fda decision on postpartum depression drug

The FDA approved the pill Zuranolone, developed by Sage and Biogen, for postpartum depression but decli...

August 7, 2023, 10:52 am

Fda approves first postpartum depression pill from biogen, sage

Yahoo Finance Health care reporter Anjalee Khemlani reports on the FDA approving Zurzuvae which is the first pill to treat postpartum ...

August 7, 2023, 10:37 am

Sage therapeutics' stock craters 49% after fda approves zuranolone for postpartum depression, but not major depressive disorder

Sage Therapeutics Inc.'s stock SAGE cratered 49% in premarket trade Monday, on disappointment that the U.S. regulator approved its zuranolone treatmen...

August 7, 2023, 8:01 am

Biogen, sage face uphill battle with postpartum depression pill

The U.S. drug regulator's approval of Biogen and Sage Therapeutics' first-of-its-kind postpartum depress...

August 7, 2023, 7:39 am


Search within

Pages Search Results: